FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200436661> ?p ?o ?g. }

• W4200436661 abstract "MONALEESA-3 demonstrated an overall survival (OS) benefit for ribociclib plus fulvestrant (R+F) in postmenopausal women with hormone receptor (HR) positive, HER2 negative advanced breast cancer (ABC). This study estimated quality-adjusted (QA) survival outcomes for patients receiving R+F vs. placebo (P)+F in MONALEESA-3.Kaplan-Meier OS was partitioned into health states: (1) toxicity (TOX)=time spent with grade 3 -4 adverse events before progression (DP); (2) progression (PROG)=time between DP and death; and (3) time without symptoms or toxicity (TWiST)=time not in TOX or PROG. QA time was calculated by combining estimated mean time in each health state with treatment-group specific health-state utility values estimated using EQ-5D-5L questionnaire. Outcomes included QA progression-free survival (QAPFS), QAOS, and QA TWiST (Q-TWiST). Q-TWiST was calculated with health-state utility values for TOX and PROG defined relative to TWiST.Mean PFS and OS were significantly greater with R+F vs. P+F (difference 0.56 and 0.19 years). Mean time in TOX and TWiST were greater with R+F; mean time in PROG was greater with P+F. QAPFS was 0.45 years (95% CI 0.27 -0.63) greater with R+F than P+F (P <.001). QAOS was numerically greater with R+F vs. P+F (0.16 years, 95% CI 0.07 -0.45, P = .0569). Q-TWiST was 0.23 years greater with R+F (95% CI 0.07 -0.45, P = .0069). In a sensitivity analysis using an estimate of disutility for PROG, the difference in QAOS was 0.23 years (95% CI 0.08 -0.41, P = .0022).R+F in postmenopausal women with HR+/HER2- ABC improves QAPFS, resulting in clinically important improvements in Q-TWiST and may improve QAOS." @default.
• W4200436661 created "2021-12-31" @default.
• W4200436661 creator A5005769474 @default.
• W4200436661 creator A5007579054 @default.
• W4200436661 creator A5018111705 @default.
• W4200436661 creator A5018705003 @default.
• W4200436661 creator A5025684262 @default.
• W4200436661 creator A5035054317 @default.
• W4200436661 creator A5047277951 @default.
• W4200436661 creator A5052650382 @default.
• W4200436661 creator A5058433062 @default.
• W4200436661 creator A5071675004 @default.
• W4200436661 creator A5077816696 @default.
• W4200436661 creator A5082586328 @default.
• W4200436661 creator A5088601230 @default.
• W4200436661 date "2021-12-01" @default.
• W4200436661 modified "2023-09-26" @default.
• W4200436661 title "Quality-Adjusted Survival with Ribociclib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Postmenopausal Women with HR+/HER2− Advanced Breast Cancer in the MONALEESA-3 Trial" @default.
• W4200436661 cites W1801015153 @default.
• W4200436661 cites W2020677481 @default.
• W4200436661 cites W2033521428 @default.
• W4200436661 cites W2074057249 @default.
• W4200436661 cites W2093030413 @default.
• W4200436661 cites W2116144791 @default.
• W4200436661 cites W2792113799 @default.
• W4200436661 cites W2805575723 @default.
• W4200436661 cites W2898442447 @default.
• W4200436661 cites W2945409099 @default.
• W4200436661 cites W3016908890 @default.
• W4200436661 cites W3133509869 @default.
• W4200436661 cites W4239051461 @default.
• W4200436661 doi "https://doi.org/10.1016/j.clbc.2021.12.008" @default.
• W4200436661 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35034858" @default.
• W4200436661 hasPublicationYear "2021" @default.
• W4200436661 type Work @default.
• W4200436661 citedByCount "0" @default.
• W4200436661 crossrefType "journal-article" @default.
• W4200436661 hasAuthorship W4200436661A5005769474 @default.
• W4200436661 hasAuthorship W4200436661A5007579054 @default.
• W4200436661 hasAuthorship W4200436661A5018111705 @default.
• W4200436661 hasAuthorship W4200436661A5018705003 @default.
• W4200436661 hasAuthorship W4200436661A5025684262 @default.
• W4200436661 hasAuthorship W4200436661A5035054317 @default.
• W4200436661 hasAuthorship W4200436661A5047277951 @default.
• W4200436661 hasAuthorship W4200436661A5052650382 @default.
• W4200436661 hasAuthorship W4200436661A5058433062 @default.
• W4200436661 hasAuthorship W4200436661A5071675004 @default.
• W4200436661 hasAuthorship W4200436661A5077816696 @default.
• W4200436661 hasAuthorship W4200436661A5082586328 @default.
• W4200436661 hasAuthorship W4200436661A5088601230 @default.
• W4200436661 hasConcept C121608353 @default.
• W4200436661 hasConcept C126322002 @default.
• W4200436661 hasConcept C142724271 @default.
• W4200436661 hasConcept C143998085 @default.
• W4200436661 hasConcept C197934379 @default.
• W4200436661 hasConcept C204787440 @default.
• W4200436661 hasConcept C207103383 @default.
• W4200436661 hasConcept C2524010 @default.
• W4200436661 hasConcept C27081682 @default.
• W4200436661 hasConcept C2776196297 @default.
• W4200436661 hasConcept C2780482068 @default.
• W4200436661 hasConcept C29456083 @default.
• W4200436661 hasConcept C3018603563 @default.
• W4200436661 hasConcept C33923547 @default.
• W4200436661 hasConcept C44249647 @default.
• W4200436661 hasConcept C530470458 @default.
• W4200436661 hasConcept C71924100 @default.
• W4200436661 hasConcept C84606932 @default.
• W4200436661 hasConcept C90924648 @default.
• W4200436661 hasConceptScore W4200436661C121608353 @default.
• W4200436661 hasConceptScore W4200436661C126322002 @default.
• W4200436661 hasConceptScore W4200436661C142724271 @default.
• W4200436661 hasConceptScore W4200436661C143998085 @default.
• W4200436661 hasConceptScore W4200436661C197934379 @default.
• W4200436661 hasConceptScore W4200436661C204787440 @default.
• W4200436661 hasConceptScore W4200436661C207103383 @default.
• W4200436661 hasConceptScore W4200436661C2524010 @default.
• W4200436661 hasConceptScore W4200436661C27081682 @default.
• W4200436661 hasConceptScore W4200436661C2776196297 @default.
• W4200436661 hasConceptScore W4200436661C2780482068 @default.
• W4200436661 hasConceptScore W4200436661C29456083 @default.
• W4200436661 hasConceptScore W4200436661C3018603563 @default.
• W4200436661 hasConceptScore W4200436661C33923547 @default.
• W4200436661 hasConceptScore W4200436661C44249647 @default.
• W4200436661 hasConceptScore W4200436661C530470458 @default.
• W4200436661 hasConceptScore W4200436661C71924100 @default.
• W4200436661 hasConceptScore W4200436661C84606932 @default.
• W4200436661 hasConceptScore W4200436661C90924648 @default.
• W4200436661 hasLocation W42004366611 @default.
• W4200436661 hasLocation W42004366612 @default.
• W4200436661 hasOpenAccess W4200436661 @default.
• W4200436661 hasPrimaryLocation W42004366611 @default.
• W4200436661 hasRelatedWork W1802829593 @default.
• W4200436661 hasRelatedWork W2055804777 @default.
• W4200436661 hasRelatedWork W2057553101 @default.
• W4200436661 hasRelatedWork W2059667954 @default.
• W4200436661 hasRelatedWork W2071535312 @default.
• W4200436661 hasRelatedWork W2224319365 @default.
• W4200436661 hasRelatedWork W2588299166 @default.
• W4200436661 hasRelatedWork W2969537103 @default.

• next